news

Our latest
Press Releases & Updates

Latest press releases

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

Ikerian has secured USD 8M (CHF 6.73M) in the first close of its Series B round, led by Sanoptis, to enhance its AI-driven RetinAI Discovery platform and expand into new therapeutic areas.

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

RetinAI partners with MAXO and TFS HealthScience to support two pivotal dry eye disease studies.

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing

Latest updates

5th international Congress OCT Angiography [DECEMBER'17]

RetinAI will be presenting the latest company's developments in this year's edition of the 5th International Congress on OCT Angiography in Rome, on the 15-16th December. Don't forget to come to our session: Unleashing the potential of longitudinal image analysis in Optical Coherence Tomography.

NVIDIA GTC Munich 2017 [OCTOBER'17]

RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.

5th Medtech & Digital Health Forum Basel [OCTOBER'17]

RetinAI participated in the latest edition of the 5th Medtech & Digital Health Forum in Basel. The team had the opportunity to present our current developments and efforts towards bringing Artificial Intelligence to Ophthalmology, specially in developing countries.

Euretina 2017 + MICCAI 2017 [AUGUST'17]

RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.

Contact us for more informations! We are happy to hear from you!